Gitnux/Report 2026

AI Chemistry Industry Statistics

The global AI in chemicals market reached $2.0 billion in 2026, explore the figures behind growth, company capabilities, and integration-to-lab trends.
24Statistics
33Sources
5Sections
15mRead
AI Chemistry Industry Statistics
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The AI chemistry industry at a glance

AI in chemicals reached an estimated $2.0 billion in 2026 and is forecast to expand rapidly as manufacturers adopt software for production optimization, material discovery and process management.

$2.0B[5]
Global market estimate, 2026
28.0%[5]
Forecast CAGR, 2026–2033
40.2%[5]
North America share, 2025
49.3%[5]
Software segment share, 2025
Market size
The global AI in chemicals market was estimated at $1.5 billion in 2025 and $2.0 billion in 2026, according to Grand View Research. The market definition covers AI applications across chemical production, material innovation and related operational functions.[5]
Forecast & CAGR
The market is forecast to reach $11.0 billion by 2033, implying a 28.0% compound annual growth rate from 2026 to 2033. North America's regional market is projected to grow at a 29.0% CAGR over the same period.[5]
Market share & regions
North America held 40.2% of global AI in chemicals revenue in 2025, with regional revenue of $616.9 million. Asia Pacific is identified as the fastest-growing region and is projected to reach $2.84 billion by 2033.[5]
Segmentation
Software represented 49.3% of market revenue in 2025, while production optimization was the largest application at 28.2%. By end use, base chemicals and petrochemicals accounted for 40.5% of revenue in 2025.[5]
Key players & concentration
Named participants include Accenture, BASF, Google, Honeywell, IBM, Insilico Medicine, Microsoft, NVIDIA, Siemens and SLB. The available market source identifies leading companies but does not disclose a combined market share or concentration ratio.[5]
Trends, drivers & challenges
Adoption is being driven by demand for faster molecule and material discovery, production optimization, predictive maintenance and lower operating costs. The sector remains constrained by the need to connect AI models with physical experiments, automated laboratories and reliable chemical data; a 2025 ACS investment report highlighted ChemLex's $45 million financing for AI-enabled synthesis planning and automated laboratory infrastructure.[5][13]
M&A
M&A data for the standalone AI chemistry industry is limited. In a disclosed 2025 transaction, Shuttle Pharmaceuticals acquired substantially all assets and liabilities of Molecule.ai, whose platform uses AI to predict molecular properties and support early-stage drug development; the filing did not report a purchase price.[14]
Regulation
U.S. policy requires agencies to develop evaluations and guidance for advanced AI models that could generate or exacerbate chemical threats, including models trained substantially on chemical data. In the European Union, Regulation 2025/2455 requires a common data platform for chemicals and an early-warning system for emerging chemical risks by January 2, 2027.[15][16]
Latest news
In October 2026, chemistry-native AI company Albert announced a $55 million Series B financing to expand AI capabilities and research and manufacturing capacity for critical materials. In 2025, Chemify raised $50 million to develop its AI-based Chemputation system and automated chemical production platform.[17][18]

02 Ranking

Top 10 Companies in the AI Chemistry Industry

The leading companies in the AI chemistry industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Insilico Medicine stands out for integrating generative AI across biology, chemistry, and clinical development because its Pharma.AI platform applies generative AI across biology, chemistry and clinical development, while Isomorphic Labs is the pick for drug discovery since it applies AlphaFold-derived AI and has major pharmaceutical collaborations.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in molecule & target discovery

    Insilico Medicine

    HK

    Ranked #1 · 9.4 · Molecule & target discovery

    Why we picked it: It integrates generative AI across biology and chemistry workflows through Pharma.AI.

  2. Leader in AI-accelerated molecular simulation

    Schrödinger

    US

    Ranked #3 · 9.0 · AI-accelerated molecular simulation

    Why we picked it: Its physics-based simulation and AI/ML platform spans molecular discovery and therapeutics.

  3. Leader in quantum robotics R&D

    XtalPi

    CN

    Ranked #4 · 8.9 · Quantum robotics R&D

    Why we picked it: It combines quantum physics, AI, cloud computing, and robotics for drug and materials R&D.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the AI chemistry industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Insilico Medicine

Molecule & target discovery · HK

9.4
2

Isomorphic Labs

Molecule & target discovery · GB

9.1
3

Schrödinger

AI-accelerated molecular simulation · US

9.0
4

XtalPi

Quantum robotics R&D · CN

8.9
5

Generate Biomedicines

Generative protein design · US

8.9
6

Chai Discovery

AI molecular design and structure prediction · US

8.5
7

Citrine Informatics

AI materials and chemicals development platform · US

8.4
8

Chemify

AI molecular design and automated chemical synthesis · GB

8.3
9

Kebotix

AI and self-driving labs for materials discovery · US

8.2
10

Evogene

Generative AI small-molecule discovery for pharma and agriculture · IL

7.8

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the AI chemistry industry. In AI Chemistry Industry Statistics. Gitnux. https://gitnux.org/ai-chemistry-industry-statistics/#top-companies

04 Statistics

Technology & AI

Reported usage remains measured but progressing: 25% of 530 chemistry professionals used generative-AI chat tools more than once a month in fall 2024.

AI features and adoption in the AI chemistry industry

  • 25% of 530 chemistry professionals used generative-AI chat tools more than once a month in fall 2024, indicating measured usage of AI-enabled chemistry software and platforms.[1]
  • 25% of more than 110 life-sciences laboratory professionals reported generative AI in full production, a parent-category proxy covering chemistry, biology, clinical and manufacturing laboratories.[2]
  • 16% of 530 chemistry professionals said generative AI substantially improved productivity in their work or research in fall 2024, measuring perceived adoption value of AI-enabled chemistry tools.[1]
  • 5% of more than 110 life-sciences laboratory professionals reported AI agents in production, a parent-category proxy covering chemistry and other laboratory environments.[2]

05 Statistics

Market Intelligence

Software is the nearest paid proxy for AI chemistry spend, with a 2026 global revenue estimate of US$1.28 billion for software within AI drug discovery.

Market size and revenue in the AI chemistry industry

  • US$1.28 billion was the 2026 global revenue estimate for software within AI drug discovery, the closest published software-only proxy for paid AI chemistry software; the source distinguishes it from US$2.72 billion of services.[3]
  • US$3.92 billion was the 2025 global market size for AI in drug discovery, a parent category encompassing paid AI chemistry and drug-discovery software, services and platforms; MarketsandMarkets is cited by VI Partners.[4]
  • US$2.3 billion was the 2025 global market size for AI in drug discovery, a parent category encompassing paid AI chemistry and drug-discovery software, services and platforms; Grand View Research defines the category by application, therapeutic area, end use and region.[5]
  • US$1.13 billion was the 2025 global market size for AI in drug discovery, a parent category encompassing paid AI chemistry and drug-discovery software, services and platforms; Research and Markets is cited by VI Partners.[4]

Growth forecasts for the AI chemistry industry

  • US$2.29 billion is projected for the global AI-in-drug-discovery market by 2031, from US$1.13 billion in 2025, implying approximately a 12.5% CAGR; the scope includes paid AI chemistry and drug-discovery software, services and platforms.[4]
  • US$17.56 billion is projected for the global AI-in-drug-discovery market by 2031, from US$3.92 billion in 2025, implying a 28.1% CAGR; the scope includes paid AI chemistry and drug-discovery software, services and platforms.[4]
  • US$13.8 billion is projected for the global AI-in-drug-discovery market by 2033, from US$2.9 billion in 2026, implying a 24.8% CAGR; the scope includes AI chemistry and drug-discovery software, services and platforms.[5]

06 Statistics

Strategy & Growth

M&A activity is active in the wider AI-driven drug-discovery category, with 99 AI/ML drug-discovery and licensing transactions totaling $12.3 billion in 2025.

M&A and consolidation in the AI chemistry industry

  • 99 AI/ML drug-discovery and licensing M&A transactions totaled $12.3 billion in 2025, including contingent consideration; the study covers the wider AI-driven drug-discovery category containing AI chemistry software.[6]
  • $11.3 billion, or approximately 91.9% of the $12.3 billion AI/ML drug-discovery M&A value, was paid in cash in 2025; the study covers the wider category containing AI chemistry software.[6]
  • 10 AI drug-discovery M&A exits occurred from 2023 through 2024, more than doubling the category’s historical M&A activity; the dataset covers over 500 AI drug-discovery companies and includes AI chemistry applications.[7]

07 Statistics

Pricing & Packaging

Published subscription pricing is visible in sampled tiers, including $200 per month for Elementics AI and $14.99 per month for Atomly, observed in November 2026.

Price levels in the AI chemistry industry

  • $200 per month is the published Pro-tier price for Elementics AI’s high-throughput chemistry R&D platform, observed in November 2026 in the published sample.[8]
  • $14.99 per month is the Pro-tier price for Atomly’s AI chemistry tutor, observed in November 2026 in the published sample.[9]
  • $9 per month is the student-tier price for ChemITrust AI’s chemistry software, observed in November 2026 in the published sample.[10]
  • $5.99 per month is the Starter-tier price for Atomly’s AI chemistry tutor, observed in November 2026 in the published sample.[9]
  • $60 per month is the Premium-tier price for ChemITrust AI’s chemistry software for professional users, observed in November 2026 in the published sample.[10]

08 Statistics

Finance

Venture funding levels provide supply-side context, with European techbio and AI drug-discovery startups raising more than $2 billion in 2025.

Funding and investment in the AI chemistry industry

  • European techbio and AI drug-discovery startups raised more than $2 billion in 2025, up from $1.6 billion in 2024; the scope includes AI chemistry software and related platforms.[11]
  • $3.8 billion of equity funding went to AI in drug R&D worldwide in 2024, covering more than 500 companies applying AI to drug discovery; this parent-category figure includes AI chemistry software.[7]
  • $1.6 billion of 2024 equity funding went to AI-derived biologics and $1.0 billion to AI-derived small molecules worldwide, segments containing AI chemistry platforms and discovery engines.[7]
  • Albert Invent raised $22.5 million in a Series A in December 2024 for its AI chemistry platform, evidencing venture funding available to commercial chemistry-software providers.[12]
  • European chemical-synthesis startups raised more than $200 million in 2025, up from $73 million in 2024; this segment is a narrower proxy for AI chemistry and automated synthesis platforms.[11]

Key questions about the AI chemistry industry

What is the 2026 market size for AI in chemicals?
The global AI in chemicals market is estimated at $2.0 billion in 2026, according to Grand View Research.
How fast is the AI chemistry market growing through 2033?
The market is forecast to reach $11.0 billion by 2033, implying a 28.0% compound annual growth rate from 2026 to 2033.
Which companies lead the AI chemistry industry?
Insilico Medicine stands out for integrating generative AI across biology, chemistry, and clinical development because its Pharma.AI platform applies generative AI across biology, chemistry and clinical development, while Isomorphic Labs is the pick for drug discovery since it applies AlphaFold-derived AI and has major pharmaceutical collaborations.
What technology shift is most visible in AI chemistry tools?
Chemistry-native models are displacing generic tools, driven by demand for faster molecule and material discovery and production optimization.
How is the market structured by software versus other work?
Software represented 49.3% of market revenue in 2025, while production optimization was the largest application at 28.2%.
What limits adoption when moving from models to lab and plant execution?
The sector is constrained by the need to connect AI models with physical experiments, automated laboratories, and reliable chemical data.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). AI Chemistry Industry Statistics. Gitnux. https://gitnux.org/ai-chemistry-industry-statistics
MLA
Samuel Norberg. "AI Chemistry Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/ai-chemistry-industry-statistics.
Chicago
Samuel Norberg. 2026. "AI Chemistry Industry Statistics." Gitnux. https://gitnux.org/ai-chemistry-industry-statistics.